Market research
GLOB Globant SA
NYSE USD Technology
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 2B
- P/E ratio
- 17.06
- Analyst target
- 52
- Dividend yield
- Not available
- Beta
- 0.97
Profile
Instrument facts
- Exchange
- NYSE
- Currency
- USD
- Sector
- Technology
- Industry
- Information Technology Services
- ISIN
- LU0974299876
- Market cap
- 2B
- P/E ratio
- 17.06
- Analyst target
- 52
- Dividend yield
- Not available
- Beta
- 0.97
About
About Globant SA
Globant S.A., together with its subsidiaries, provides technology services in the United States, rest of North America, Latin America, Europe, and internationally. The company offers Digital Studio, which integrates artificial intelligence into the software development; GUT Studio, which allows clients to better connect brands; and Enterprise Studio, which leverages technology for streamlined operations and productivity. It also provides AI Industry Studios for the financial services; media, entertainment, sports, and leisure; healthcare and life sciences; CPG, retail, and automotive; gaming and EdTech; airlines; energy, oil, and gas; and high tech and professional services sectors. In addition, the company offers AI Pods, a subscription-based delivery model for AI-powered services; Globant Enterprise AI, an agentic innovation platform; Corporate Hub, which grounds intelligence in how the organization operates; AI Hub, which connects and governs foundation and custom models, continuous evaluation, and optimization; and Agents Hub, which enables autonomous action through the creation and coordination of agents and agentic workflows. Further, it provides GeneXus for enterprise systems evolution; Globant CODA for software development; Navigate Digital Twin for process optimization; Navigate Service Assist for support; and Fusion, for marketing, communications, and advertising, as well as StarMeUp, an employee engagement and talent experience platform; and DaXia, an embedded finance accelerator platform. Globant S.A. has a strategic collaboration with Pharma Mar, S.A. for cancer drug discovery through artificial intelligence; and Viability and Cascadience LLC to launch AI-powered platform for students with disabilities. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg, Luxembourg.
Research context
Globant SA appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Technology
- Industry
- Information Technology Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the GLOB discussion.
5 years, 7 months ago
Globant S.A is currently in a long term uptrend where the price is trading 3.5% above its 200 day moving average.
From a valuation standpoint, the stock is 59.6% cheaper than other stocks from the Technology sector with a price to sales ratio of 10.2.
Globant S.A's total revenue rose by 26.2% to $233M since the same quarter in the previous year.
Its net income has increased by 38.9% to $19M since the same quarter in the previous year.
Finally, its free cash flow fell by 0.0% to $-5M since the same quarter in the previous year.
Based on the above factors, Globant S.A gets an overall score of 4/5.